In conclusion, this EBMT transplant-specific risk score could improve prediction of outcome for MDS patients undergoing allogeneic stem-cell transplantation.

This proposed transplant-specific risk score offers improved performance with respect to post-transplant risk stratification in myelodysplastic syndromes.

The aim of this study was to develop and validate a clinical and trans- plant-specific prognostic score using data from a large cohort of.

Dec 8, 2017 · Recently, two scores were developed to predict outcome of MDS patients following allo-SCT: the transplantation risk index (TRI) by GITMO and the ...

Optimized EBMT transplant-specific risk score in myelodysplastic syndromes after allogeneic stem-cell transplanta- tion. Haematologica.2019;104(5):929-936 ...

Transplant-specific EBMT scoring system improves prognostic capability in myelodysplastic syndromes after allogeneic stem-cell transplantation. Nico ...

We review contemporary prognostic scoring systems in hematopoietic stem cell transplantation. Strengths and limitations of each system are described.

Mar 30, 2017 · Superior survival after treatment with HMA may be predicted in patients with a HMA therapy-specific risk score (zero points), based on absence ...

Optimized EBMT transplant-specific risk score in myelodysplastic syndromes after allogeneic stem-cell transplantation. Haematologica. 2019; 104:929-936.